VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $455,534 | -21.9% | 16,928 | -12.7% | 0.04% | -17.3% |
Q2 2023 | $583,590 | -26.8% | 19,382 | -21.4% | 0.05% | -33.3% |
Q1 2023 | $797,324 | +64.7% | 24,647 | +22.7% | 0.08% | +44.4% |
Q3 2022 | $484,000 | -4.9% | 20,080 | +8.1% | 0.05% | -3.6% |
Q2 2022 | $509,000 | -27.0% | 18,580 | +2.3% | 0.06% | -17.6% |
Q1 2022 | $697,000 | +41.7% | 18,167 | +18.7% | 0.07% | +44.7% |
Q4 2021 | $492,000 | +20.0% | 15,301 | +9.9% | 0.05% | +6.8% |
Q3 2021 | $410,000 | -15.6% | 13,920 | -2.7% | 0.04% | -13.7% |
Q2 2021 | $486,000 | +69.9% | 14,299 | +62.7% | 0.05% | +50.0% |
Q1 2021 | $286,000 | +1.1% | 8,788 | +11.8% | 0.03% | -5.6% |
Q4 2020 | $283,000 | -9.6% | 7,857 | -1.7% | 0.04% | -21.7% |
Q3 2020 | $313,000 | -32.0% | 7,993 | -36.2% | 0.05% | -37.8% |
Q2 2020 | $460,000 | +58.1% | 12,529 | -0.7% | 0.07% | +32.1% |
Q1 2020 | $291,000 | -29.0% | 12,617 | -9.9% | 0.06% | -15.2% |
Q4 2019 | $410,000 | -6.6% | 13,999 | -14.7% | 0.07% | -14.3% |
Q3 2019 | $439,000 | -0.5% | 16,417 | -4.8% | 0.08% | -2.5% |
Q2 2019 | $441,000 | -78.6% | 17,238 | -93.7% | 0.08% | +203.8% |
Q3 2018 | $2,065,000 | -6.3% | 274,786 | +465.0% | 0.03% | +4.0% |
Q2 2018 | $2,203,000 | +266.6% | 48,638 | +89.1% | 0.02% | -88.7% |
Q3 2016 | $601,000 | – | 25,718 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
Brown University | 541,096 | $19,490,000 | 14.10% |
Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |